Corcept: Q4 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

MENLO PARK, Calif. (AP) — MENLO PARK, Calif. (AP) — Corcept Therapeutics Inc. (CORT) on Thursday reported fourth-quarter earnings of $31.1 million.

On a per-share basis, the Menlo Park, California-based company said it had profit of 28 cents.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 25 cents per share.

The drug developer posted revenue of $135.4 million in the period.

For the year, the company reported profit of $105.5 million, or 94 cents per share. Revenue was reported as $482.4 million.

Corcept expects full-year revenue in the range of $600 million to $630 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CORT at https://www.zacks.com/ap/CORT

Advertisement

Recommended Stories